"Designing Growth Strategies is in our DNA"

Cystic Fibrosis Market Size, Share & Covid-19 Impact Analysis, By Drug Class (Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, and Hospital Pharmacies), and Regional Forecast, 2020-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI102958

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. New Product Launches
    2. Prevalence of Cystic Fibrosis
    3. Pipeline Analysis
    4. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
  5. Global Cystic Fibrosis Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
      2. Bronchodilators
      3. Mucolytic
      4. Pancreatic Enzyme Supplement
      5. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia pacific
      4. Rest of the World
  6. North America Cystic Fibrosis Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
      2. Bronchodilators
      3. Mucolytic
      4. Pancreatic Enzyme Supplement
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Cystic Fibrosis Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
      2. Bronchodilators
      3. Mucolytic
      4. Pancreatic Enzyme Supplement
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia pacific Cystic Fibrosis Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
      2. Bronchodilators
      3. Mucolytic
      4. Pancreatic Enzyme Supplement
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Cystic Fibrosis Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
      2. Bronchodilators
      3. Mucolytic
      4. Pancreatic Enzyme Supplement
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
  10. Cystic Fibrosis Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
      2. Bronchodilators
      3. Mucolytic
      4. Pancreatic Enzyme Supplement
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Vertex Pharmaceuticals Incorporated
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. AbbVie Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Gilead Sciences, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Mylan N.V.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Bayer AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Genentech, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. AstraZeneca
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Other Prominent Market Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Cystic Fibrosis Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2:  Global Cystic Fibrosis Market Value Share (%), by Drug Class, 2019 & 2027

Figure 3:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), 2016-2027

Figure 4:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Bronchodilators, 2016-2027

Figure 5:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Mucolytic, 2016-2027

Figure 6:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Pancreatic Enzyme Supplement, 2016-2027

Figure 7:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Others, 2016-2027

Figure 8:  Global Cystic Fibrosis Market Value Share (%), by Route of Administration, 2019 & 2027

Figure 9:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Oral, 2016-2027

Figure 10:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Parenteral, 2016-2027

Figure 11:  Global Cystic Fibrosis Market Value Share (%), by Distribution Channels, 2019 & 2027

Figure 12:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Hospital Pharmacies, 2016-2027

Figure 13:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Retail Pharmacies & Drug Stores, 2016-2027

Figure 14:  Global Cystic Fibrosis Market Forecast (US$ Bn), by Online Pharmacies, 2016-2027

Figure 15:  Global Cystic Fibrosis Market Value (US$ Bn), by Region, 2019 & 2027

Figure 16:  North America Cystic Fibrosis Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 17:  North America Cystic Fibrosis Market Value Share (%), by Drug Class, 2019

Figure 18:  North America Cystic Fibrosis Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 19:  North America Cystic Fibrosis Market Value Share (%), by Route of Administration, 2019

Figure 20:  North America Cystic Fibrosis Market Value (US$ Bn), by Distribution Channels, 2019 & 2027

Figure 21:  North America Cystic Fibrosis Market Value Share (%), by Distribution Channels, 2019

Figure 22:  North America Cystic Fibrosis Market Value (US$ Bn), By Country, 2019 & 2027

Figure 23:  North America Cystic Fibrosis Market Value Share (%), By Country, 2019

Figure 24:  Europe Cystic Fibrosis Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 25:  Europe Cystic Fibrosis Market Value Share (%), by Drug Class, 2019

Figure 26:  Europe Cystic Fibrosis Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 27:  Europe Cystic Fibrosis Market Value Share (%), by Route of Administration, 2019

Figure 28:  Europe Cystic Fibrosis Market Value (US$ Bn), by Distribution Channels, 2019 & 2027

Figure 29:  Europe Cystic Fibrosis Market Value Share (%), by Distribution Channels, 2019

Figure 30:  Europe Cystic Fibrosis Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 31:  Europe Cystic Fibrosis Market Value Share (%), By Country/ Sub-region, 2019

Figure 32:  Asia Pacific Cystic Fibrosis Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 33:  Asia Pacific Cystic Fibrosis Market Value Share (%), by Drug Class, 2019

Figure 34:  Asia Pacific Cystic Fibrosis Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 35:  Asia Pacific Cystic Fibrosis Market Value Share (%), by Route of Administration, 2019

Figure 36:  Asia Pacific Cystic Fibrosis Market Value (US$ Bn), by Distribution Channels, 2019 & 2027

Figure 37:  Asia Pacific Cystic Fibrosis Market Value Share (%), by Distribution Channels, 2019

Figure 38:  Asia Pacific Cystic Fibrosis Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 39:  Asia Pacific Cystic Fibrosis Market Value Share (%), By Country/ Sub-region, 2019

Figure 40:  Rest of the World Cystic Fibrosis Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 41:  Rest of the World Cystic Fibrosis Market Value Share (%), by Drug Class, 2019

Figure 42:  Rest of the World Cystic Fibrosis Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 43:  Rest of the World Cystic Fibrosis Market Value Share (%), by Route of Administration, 2019

Figure 44:  Rest of the World Cystic Fibrosis Market Value (US$ Bn), by Distribution Channels, 2019 & 2027

Figure 45:  Rest of the World Cystic Fibrosis Market Value Share (%), by Distribution Channels, 2019

Figure 46:  Global Cystic Fibrosis Market Share (%), By Company, 2019

Table 1:  Global Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Drug Class, 2016–2027

Table 2:  Global Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016–2027

Table 3:  Global Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016–2027

Table 4:  Global Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 5:  North America Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 6:  North America Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 7:  North America Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016-2027

Table 8:  North America Cystic Fibrosis Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 9:  Europe Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 10:  Europe Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 11:  Europe Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016-2027

Table 12:  Europe Cystic Fibrosis Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 13:  Asia Pacific Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 14:  Asia Pacific Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 15:  Asia Pacific Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016-2027

Table 16:  Asia Pacific Cystic Fibrosis Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 17:  Rest of the World Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 18:  Rest of the World Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 19:  Rest of the World Cystic Fibrosis Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016-2027

Table 20:  Rest of the World Cystic Fibrosis Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Cystic Fibrosis Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?